1. Kokic
M
. World Health Organization [WHO]. Asthma. Geneva, Switzerland: 2022. Accessed February 21, 2023. https://www.who.int/news-room/fact-sheets/detail/asthma
2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Vos;The Lancet,2020
3. Zablotsky
B
, BlackLI, AkinbamiLJ. Diagnosed allergic conditions in children aged 0–17 years: United States, 2021. Hyattsville, MD; 2023. Accessed February 20, 2023. https://www.cdc.gov/nchs/products/databriefs/db459.htm
4. Global Initiative for Asthma [GINA]. Global strategy for asthma management and prevention. 2022. Accessed February 21, 2023. https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf
5. US Food and Drug Administration [FDA]. FDA requires boxed warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis. Silver Spring, MD: 2020. Accessed February 21, 2023. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug